Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | THRA | P10827 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11811972 | 0.95 | THRA (0.40) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL4020624 | 0.94 | THRA (0.42) | CYP3A4THRATHRBLIPGTYR | |
| SCHEMBL677297 | 0.83 | LIPG (0.39) | CYP3A4CYP2D6CYP2C9LIPGTYR | |
| SCHEMBL3267471 | 0.83 | THRB (0.37) | THRATHRBLIPGGABRA1GABRB2 | |
| SCHEMBL7726842 | 0.81 | THRA (0.39) | THRATHRBLIPGGABRA1GABRB2 | |
| SCHEMBL7828514 | 0.81 | LIPG (0.38) | CYP3A4CYP2D6CYP2C9LIPGTYR | |
| SCHEMBL176260 | 0.81 | GABRA1 (0.42) | GABRA1GABRB2 | |
| SCHEMBL817104 | 0.80 | LIPG (0.44) | CYP3A4LIPGTYRALOX5PTGS2 | |
| SCHEMBL7267794 | 0.80 | LIPG (0.44) | CYP3A4LIPGTYRALOX5PTGS2 | |
| SCHEMBL983670 | 0.78 | LIPG (0.47) | CYP3A4THRATHRBLIPGTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050182219-A1 | Crystallization inhibitor for plant-protective formulations | MEYER GERD R (DE) | 2005-08-18 | — | — | US | claimed |
| US-9801372-B2 | Polymers for increasing the soil mobility of low-solubility insecticides | BASF SE (DE) | 2017-10-31 | — | — | US | disclosed |
| US-20120053221-A1 | Polymers for Increasing the Soil Mobility of Low-Solubility Insecticides | BASF SE (DE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053221-A1 | Polymers for Increasing the Soil Mobility of Low-Solubility Insecticides | SMARCA1, PWWP2B, SMARCB1 | CYP3A4 1356/4885CYP2D6 2183/4885CYP2C9 1111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.